|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
26 September 2016 |
|
Main ID: |
NCT02903797 |
|
Date of registration:
|
13/09/2016 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Irisin Hormone Levels in Endometrial Hyperplasia
|
|
Scientific title:
|
The Relation Between Serum Irisin Hormone Level and Endometrial Hyperplasia |
|
Date of first enrolment:
|
August 2016 |
|
Target sample size:
|
80 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT02903797 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case Control, Time Perspective: Retrospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Turkey
| | | | | | | |
|
Contacts
|
|
Name:
|
Erdem SAHIN, Principal Investigator |
|
Address:
|
|
|
Telephone:
|
+905321688683 |
|
Email:
|
erdemsahin07@hotmail.com |
|
Affiliation:
|
|
|
|
Name:
|
Erdem SAHIN |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Kayseri Training and Research Hospital |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- between 35-50 years of age
- In endometrial hyperplasia group; patients who were diagnosed endometrial hyperplasia
histopathologically
Exclusion Criteria:
- Pregnancy
- Liver function disorders
- Cardiovascular disease
- Metabolic disease
- Diabetes
- Chronic kidney disease
- Central nerves system disease
- Immunosuppressive drug use
- Another known malignancy
- Excessive exercises in among one month
Age minimum:
35 Years
Age maximum:
50 Years
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Endometrial Hyperplasia
|
|
Primary Outcome(s)
|
|
Serum irisin hormone levels in endometrial hyperplasia
[Time Frame: 6 months]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|